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ABSTRAK
Sindrom usus iritabel (irritable bowel syndrome/IBS) merupakan salah satu kelainan gastrointestinal 
fungsional yang paling sering dijumpai pada lansia. IBS ditandai dengan adanya sakit perut disertai dengan 
perubahan kebiasaan buang air besar tanpa adanya patologi organik yang spesifik. Diagnosis IBS umumnya 
ditegakkan berdasarkan kriteria klinis. Saat ini, kriteria Roma III merupakan kriteria terpilih untuk mendefinisikan 
IBS. Namun, penuaan itu sendiri merupakan salah satu dari gejala alarm pada diagnosis IBS yang memerlukan 
pengawasan lebih lanjut. Oleh karena itu, eksklusi terhadap keberadaan penyakit organik, dengan menggunakan 
pendekatan-pendekatan tertentu, merupakan sebuah hal yang sangat penting untuk diterapkan pada pasien 
lansia. Umumnya, terapi IBS pada lansia tidak berbeda dengan populasi yang lebih muda. Tetapi, dibutuhkan 
perhatian dan pertimbangan yang lebih besar sebelum memberikan terapi dengan obat-obatan dikarenakan 
adanya perubahan pada rasio resiko-manfaat pada lansia. Sejumlah studi telah menunjukkan bahwa terdapat 
hubungan yang kuat antara IBS dengan kondisi psikiatri. Maka, tatalaksana psikologis juga harus diberikan 
di dalam manajemen IBS pada lansia.
Kata kunci: sindrom usus iritabel, lansia, manajemen.
ABSTRACT
Irritable bowel syndrome (IBS) is one of the most commonly encountered functional gastrointestinal 
disorders in the elderly. IBS is characterized by abdominal pain and altered bowel habits in the absence of 
specific organic pathology. The diagnosis of IBS usually depends primarily on established clinical criteria. 
Currently, Rome III criteria are the criteria of choice for defining IBS. However, aging itself is categorized as 
one of the alarm symptoms in the diagnosis of IBS that may warrant further investigation. Therefore, exclusion 
of organic diseases, using several investigations, is of paramount important in the older patients. In general, the 
treatment of IBS in the elderly is not different from the younger populations. However, greater caution needs to 
be considered before treating with drugs because of the altered risk-benefit profile in the elderly. Several studies 
have shown a strong relationship of IBS with psychiatric conditions. Thus, psychological treatments should also 
be considered in the management of IBS in the elderly.
Key words: irritabel bowel syndrome, elderly, management.
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INTRODUCTION
Irritable Bowel Syndrome (IBS) is frequently 
occured in the clinical practice. IBS is considered 
as a functional disorder, since the presence of IBS 
is not associated with any organic abnormalities, 
either structural or biochemical. IBS can be 
assessed by symptom-based diagnostic criteria, 
which is known as the Rome criteria. Currently, 
Rome III diagnostic criteria has been used 
widely in establishing the diagnosis of IBS. In 
the absence of any alarm symptoms, including 
weight loss, as well as gastrointestinal bleeding, 
the criteria are highly predictive in defining IBS.1
The age at onset of IBS is varied. An onset 
after the age of 65 years (elderly) is extremely rare, 
as in most cases, the incidence increases during 
adolescence and young adulthood. However, 
since aging is associated with an increased 
risk of having any organic abnormalities, the 
management of IBS in the elderly is more 
difficult and complicated, when compared to the 
management of IBS in the younger populations. 
This review article focuses on the approach and 
treatment of IBS in the elderly.1
EPIDEMIOLOGY
Recent epidemiologic studies suggest that 
the prevalence of IBS in the elderly is similar 
to that in younger persons. Other studies have 
suggested that the prevalence of IBS in older 
persons is approximately about 10%-20%, 
predominantly occured in women, with a ratio of 
2 : 1. However, studies conducted in India have 
shown a different fact, that IBS is particularly 
frequent in men. The reasons of these contrary 
results are still unknown.1,2
PATHOPHYSIOLOGY
A number of mechanisms have been proposed 
in explaining the pathophysiology of IBS. 
However, the exact mechanism is still unknown. 
Some recent studies have demonstrated that 
IBS is likely caused by an interaction of multi-
factorial etiologies. It should be noted that the 
pathophysiology of IBS, which was proposed 
by recent studies, is conducted in young-adult 
populations. Thus, further studies are needed to 
confirm whether these teories can also be applied 
in the elderly population.3
Altered-gut Motility
As IBS is characterized by an altered bowel 
habit, abnormal colonic motility has been 
proposed to be the cause in the pathophysiology of 
IBS. Colonic motility, including high amplitude 
propagating contractions (HAPCs), and colonic 
transit were suggested to be increased in IBS 
patients who have diarrhea. In the contrary, in 
IBS patients with constipation, reduced colonic 
motility, fewer HAPCs, and delayed colonic 
transit has been proposed to be the likely cause. 
Furthermore, some recent studies have 
demonstrated that 5-HT (serotonin) concentration, 
which is known as a mediator in initiating colonic 
motility, was found to be increased in IBS 
patients with diarrhea. The 5-HT concentration 
was also found to be reduced in IBS patients 
with constipation. These findings may also 
strengthen the concept that altered bowel motility 
is involved in the pathophysiology of IBS.4
Visceral Hypersensitivity
As impaired in the pain perception is 
commonly occured in most patients with IBS, 
visceral hypersensitivity has also been proposed 
to be the cause in the pathophysiology of IBS. 
Several studies have suggested that chronic pain 
in IBS is occured through central and peripheral 
mechanisms.4
Tissue injury and inflammation will release a 
number of immune and inflammatory mediators. 
As this process started, the nerve terminals, 
particularly the peripheral nocireceptor terminal, 
are exposed to these mediators. Thus, a peripheral 
sensitization may be occured, and resulted in 
primary hyperalgesia (a condition where the 
nerves are more sensitive to the pain stimuli) 
and allodynia (a condition where the nerves 
interpretates non-painful stimuli as painful 
stimuli). Finally, as a result of a repeated and 
continuous stimulation to the nerves, particularly 
the sigmoid splanchnic afferents, secondary 
hyperalgesia and allodynia may occured and 
lead to the development of central sensitization.4
Psychosocial Factors
Several studies have demonstrated that 
psychological disorders, including anxiety 
and depression, is strongly associated with 
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IBS. Epidemiological studies have shown 
that psychological impairment is occured 
in approximately 50% of patients with IBS. 
Furthermore, psychosocial factors, such as 
stressful live events and personality type, have 
been proposed to affect the symptoms of IBS. 
Finally, it could be concluded that psychosocial 
factors might be involved in the pathophysiology 
of IBS.4
Brain-gut Axis
Currently, brain-gut axis is considered as a 
potential cause in the pathophysiology of IBS. 
It has been postulated that in patients with IBS, 
colonic motor response to a stress hormone 
stimulation, particularly corticotropin-releasing 
factor, is increased. As a result, gastrointestinal 
response to stress stimulation is increased. From 
these findings, it could be concluded that there 
is a strong relationship between gastrointestinal 
response and stress stimulation. Therefore, 
psychological treatment should always be 
involved in the treatment of IBS in the elderly.2
Post-infective IBS
Infectious diseases, particularly in the 
gastrointestinal tract, may play a role in the 
pathophysiology of IBS. Epidemiological studies 
have shown that IBS symptoms are occured in 
approximately 25% of people after having an 
acute gastrointestinal infection. Post-infectious 
IBS is considered as non specific to any type 
of organism, as it may occured in patients after 
having salmonella, shigella, or campylobacter 
infection. Several studies have reported that 
the post-infective IBS could not be recognized 
easily, as the macroscopic findings were normal. 
However, several abnormalities can be detected 
in microscopic examination in the biopsies of 
the gut.4,5
Microbial Flora of the Gastrointestinal Tract
In healthy persons, Bifidobacteria and 
Lactobacilli are considered as the dominant 
gastrointestinal (GI) microorganisms. Several 
studies have demonstrated that these bacteria 
may give a beneficial effect to the health of the 
host, particularly in the GI tract, as they have 
been shown to promote the release of anti-
inflammatory cytokines and inhibit the release 
of pro-inflammatory cytokines.6
However, the composition of these bacteria 
in the GI system could be altered by antibiotic 
usage, as the antibiotic may affect the life of all 
GI microorganisms, either pathogenic or non-
pathogenic bacteria. Some recent studies have 
demonstrated that the composition of bacteria 
in the GI system in patients with IBS is differ 
from healthy subjects. Thus, altered GI flora is 
considered to be strongly associated with the 
development of IBS symptoms.6
DIAGNOSIS
IBS is characterized by the presence of 
persistent symptoms, such as chronic abdominal 
pain or discomfort, and altered bowel habit, for 
at least six months, in the absence of any organic 
abnormalities, either structural or metabolic. 
Currently, Rome III criteria has been widely 
used in assessing IBS. Furthermore, it has been 
considered as the criteria of choice in defining 
IBS. However, the criteria for defining IBS in 
the elderly is not different from the younger 
populations.3,7
Table 1. Rome III criteria for defining irritable bowel 
syndrome (IBS)
Recurrent abdominal pain or discomfort for at least 3 
days per month in the last 3 months associated with 2 
or more of the following:
 - Improvement with defecation
 - Onset associated with a change in frequency of 
stool
 - Onset associated with a change in form 
(appearance) of stool
Cited from: Minocha A3 and Longstreth GF7
IBS Sub-classification
According to the Rome III criteria, IBS 
patients can be classified into three subgroups, 
based on the bowel pattern:7,8
1. IBS with diarrhea (IBS-D) : The patients are 
categorized into this group if they have loose 
stools in >25% of the time and hard stools in 
<25% of the time.
2. IBS with constipation (IBS-C) : The patients 
are categorized into this group if they have 
hard stools in >25% of the time and loose 
stools in <25% of the time.
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3. IBS with mixed bowel habits or cyclic pattern 
(IBS-M) : The patients are categorized into 
this group if they have both hard and loose 
stools in >25% of the time. 
History
IBS  pa t i en t s  shou ld  be  a s se s sed 
comprehensively. The primary presenting 
symptoms should be reviewed carefully, as 
these symptoms are considered as the main 
key in establishing the diagnosis of IBS. Other 
factors, including predisposing factors, and other 
associated symptoms, either gastrointestinal or 
extra-gastrointestinal, should also be sought 
carefully. Furthermore, it is also necessary to 
recognize the alarm symptoms early, as older 
persons have higher risks to develop serious 
disorders, including malignancy. As psyhosocial 
disorders may also play a role in the development 
of IBS, the underlying psychosocial factors 
should be sought carefully, and treated, if present. 
Principally, all IBS patients should be asked 
about the following:4,8
1. The pattern of abdominal pain or discomfor.
Typically, IBS is characterized by a 
chronic and reccurrent abdominal pain or 
discomfort. Most patients had also previous 
episodes of abdominal pain or discomfort. 
Furthermore, IBS is strongly suggested if the 
symptoms improved after the patient having 
defecation.4,8
2. Nature of the associated bowel disturbance: 
constipation, diarrhea or alternation. It is 
necesarry to categorize IBS patients based 
on the bowel pattern. The term “diarrhea” 
and “constipation” can be assessed easily 
using the Bristol Stool Chart. However, 
ocasionally, a group of patients could not 
be categorized into any subtypes, as these 
patients may experience both loose and hard 
stools together within a short period. Thus, 
these patients could be categorized as having 
“mixed” bowel habit.4,8
3. Other symptoms. Other gastrointestinal 
symptoms may commonly occured in 
patients with IBS, including bloating, 
straining, incomplete evacuation, urgency, 
incontinence, and passage of mucus 
per rectum. Furthermore, several extra-
gastrointestinal symptoms may also occured 
concomittanly in patients with IBS, and 
should be recognized early, as failure to 
recognize this may increase the cost of 
treatment due to unnecessary investigation.4,8
Alarm Symptoms
The presence of alarm symptoms, such as 
rectal bleeding, anemia, unintended weight loss, 
fever accompanying lower abdominal pain, 
and abnormal physical examination, should be 
sought carefully, as older persons have higher 
risks to develop serious disorders. Furthermore, 
a family history of serious diseases, including 
colon cancer or IBD, should also be sought 
carefully. However, aging itself is considered as 
one of the alarm symptoms. Therefore, careful 
investigations should be performed, to exclude 
organic disorders, before the diagnosis of IBS in 
the elderly was established.4
Psychological Features
IBS patients usually have psychological 
abnormalities, including anxiety, depression, 
and somatization. Psychological factors should 
be taken into consideration in the management 
of IBS, as the persistence of IBS symptoms 
is strongly associated with the impairment 
of psychological factors. Furthermore, 
psychological disorders may also reduce the 
quality of life in patients with IBS. Thus, the 
presence of psychological disorders should be 
sought carefully, and treated, if present.4,8
Physical Examination
Physical examination should be performed 
completely, as it is needed to recognize possible 
organic disorders early. However, physical 
abnormalities are usually absent in IBS patients. 
Physical examination should be initiated by 
general examination, as it is necessary to exclude 
the presence of organic diseases early. After that, 
the abdominal examination should be performed 
completely. It should be noted to review the 
patient’s pain carefully, including the location 
of pain, and the type of pain, either diffuse or 
localized, as the pain description may play an 
important role in establishing the diagnosis of 
IBS. Pain in IBS is usually visceral in origin, 
thus the presence of a well-localized pain suggest 
other diagnoses.4,8
Perianal region examination, including 
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digital rectal examination, should always be 
performed in establihing the diagnosis of IBS, 
particularly in patients with special conditions, 
such as diarrhea, or rectal bledding. Further 
investigation, including endoscopic examination, 
should be taken into consideration in patients 
with diarrhea or rectal bleeding, as it is needed to 
exclude the presence of serious organic disorders, 
such as colitis, hemorrhoid, colon or rectal 
cancer. However, aging itself is considered as 
one of the alarm symptoms, which need further 
evaluation, including endoscopic examination. 
Therefore, endoscopic examination should 
always be performed in elder patients with IBS.4,8
CLINICAL FEATURES UNIQUE TO THE 
ELDERLY
The presence of IBS in the elderly is also 
not easy to be recognized, as the presence of 
systemic disorders such as diabetes mellitus 
and polipharmacy, may cause alterations in pain 
perception. As a result, the clinical manifestation 
of IBS in the elderly is usually non-spesific. 
Unlike the younger population, the changes 
in bowel pattern in the elderly, including 
constipation, diarrhea, or alternating diarrhea 
and constipation, are frequently intermittent, 
although constipation is predominantly ocured 
in the elderly. Furthermore, as there are several 
alterations in pain perception in the elderly, the 
abdominal pain is not easy to localized. However, 
in most patients, the pain is usually localized 
in the mid and lower region of abdomen, and 
resolved after having defecation or flatus.3
Aging is associated with an increased risk 
of having several disorders, including bowel 
distention and borborygmi. The presence of these 
disorders may complicate the management of 
IBS in the elderly. Furthermore, older persons, 
particularly women, usually have an increased 
prevalence of perineal descent, which is strongly 
asssociated with difficulty in evacuation. In 
addition, the presence of geriatric problems, 
such as rectal urgency, fecal incontinence, and 
urinary problems, should also be taken into 
consideration in the management of IBS in the 
elderly. Therefore, the management of IBS in the 
elderly is more complicated, when compared to 
the younger populations.3
ASSOCIATED CONDITIONS
Some recent studies have demonstrated 
that IBS is strongly associated with several 
comorbidities which may occured concomitantly, 
including Gastroesophageal Reflux Disease 
(GERD), non-obstructive dysphagia, non-
cardiac chest pain, and functional dyspepsia. 
Patients may also experience increased gas and 
bloating, eventhough the volume of colonic gas 
is normal. Furthermore, IBS is also associated 
with several extra-gastrointestinal problems, 
including asthma, polyuria, sexual dysfunction, 
and dyspareunia. Chronic functional pain 
disorders, such as fibromyalgia, chronic fatigue 
syndrome, and migraine, may also occured 
in patients with IBS. Recent epidemiological 
studies have demonstrated that the prevalence 
of abdominal, pelvic, and back surgery is also 
increased in patients with IBS.3,4
DIFFERENTIAL DIAGNOSIS
Several organic disorders, including 
mesenteric ischemia, thyroid dysfunction, 
diabetes mellitus, depression and autonomic 
neuropathy, may give similiar symptoms to 
IBS. Thus, exclusion of these organic disorders 
is important before the diagnosis of IBS is 
established. The presence of organic disorders, 
should be taken into consideration, especially 
if the patients experience some clues which 
suggest organic disorders, such as recent onset 
and progressive symptoms, fever, vomiting, 
nocturnal pain or defecation, hematochezia, and 
unintentional weight loss. In elder men, chronic 
prostatitis should also be considered as one of the 
alternative diagnoses, as it may also give similiar 
symptoms to IBS, such as intermittent diarrhea, 
passage of mucus, and abdominal pain, as well 
as difficulty in evacuation.3
Laboratory tests play an important role in 
assessing the diagnosis of GERD, as the presence 
of any abnormalities in the laboratory results, 
including anemia, leukocytosis, abnormal liver 
enzymes, abnormal thyroid function tests, 
coagulopathy, and positive occult blood test in 
the stool examination, may suggest alternative 
diagnoses, and warrant further investigations.3
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TREATMENT STRATEGY
IBS is strongly associated with a wide 
spectrum of symptoms of varying frequencies 
and degrees of severity. It has been postulated 
that numerous factors may play a role in the 
pathophysiology of IBS, including abnormal 
motility, visceral hypersensitivity, and 
dysfunction of brain-gut regulatory system. 
Thus, there is no single or ideal medication 
in the treatment of IBS. IBS should be treated 
comprehensively, with an emphasis on the 
predominant symptom.10
Based on the clinical manifestation, patients 
with IBS can be categorized into three groups, 
such as those with mild, moderate or severe 
symptoms. The clinical profiles of each group 
can be seen in Table 2.10
groups, based on the age, such as young-old, old-
old, and frail-old. This classification is needed 
in the management of older persons with IBS, 
since each group has different problems from the 
other groups. The bowel pattern of the young-old 
patients is the same as the younger population. 
Thus, the treatment of IBS for young-old patients 
is similiar to the younger population.3
In the contrary, as aging process, significant 
changes in bowel pattern could be seen in 
older age, such as in the old-old and frail-old 
patients. Several factors may also contribute 
to the changes in the bowel pattern, including 
systemic diseases, and medications used by 
the elderly. Furthermore, unlike the younger 
population, in the frail-old patients, the risks of 
many mediactions or interventions may outweigh 
the benefits. Thus, the treatment plan should be 
arranged individually, based on the patients’ 
condition.3,10
Non-pharmacologic Therapies
In some patients, particularly those with 
mild IBS, non-pharmacological therapies, which 
is given alone, is adequate in improving the 
symptoms. In addition, it could also be given 
in combination with pharmacologic therapy, to 
achive an optimal result of treatment.10
Physician-patient Relationship. An effective 
physician-patient relationship is important in the 
treatment of IBS. Furthermore, as phycosocial 
stressors may promote the symptoms of IBS, it 
is important to search for the underlying stressor 
and correct it, if present.10
Dietary Modifications. Some recent studies 
reported that the symptoms of IBS may be created 
as a generalized response to eating. Therefore, in 
patients with IBS, it is recommended to eat small 
meals more frequently, as it may cause less stress 
on the GI tract and reduce the symptoms of IBS. 
Current studies have demonstrated that there is 
no specific diet which may promote or reduce the 
symptoms of IBS. However, in IBS patients with 
lactose intolerance, several dietary substances 
should be avoided, as they can aggrevate the 
IBS symptoms.10
As fibre and fluid intake is associated 
with improvement of IBS symptoms, it is 
recommended to increase fibre (20-30 g/day) 
Table 2. Spectrum of clinical features among patients 
with IBS
Clinical features Mild IBS
Moderate 
IBS
Severe 
IBS
Estimated prevalence 70 % 25 % 5 %
Correlation with gut 
physiology
+++ ++ +
Symptoms 0 + +++
Psychosocial difficulty 0 + +++
Health care use + ++ +++
0 = Generally Absent; + = Mild; + + = Moderate; + + + = 
Marked. (Cited from: Drossman DA10)
Some recent studies have suggested that 
the clinical symptoms of IBS are strongly 
correlated with the underlying pathophysiology. 
As mild IBS is primarily related to abnormal 
motility and/or visceral hypersensitivity, these 
symptoms can be treated by medications which 
improve the gut motility. Most patients with 
more severe symptoms of IBS usually have 
psychological disorder. It has been suggested 
that the dysfunction of brain-gut regulatory 
system may play a role in the development 
of these symptoms. Therefore, psychological 
treatment, including anti-depressan medication 
and behavioral therapy, should be involved in 
the management of these patients.10
In assessing the elderly with IBS, it is 
important to classify older persons into three 
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and fluid intake as an initial therapy for IBS 
patients. The consumption of high fiber may 
result in softer and bulkier stool, which is easier 
to defecate. Since fiber supplementation may 
increase colonic transit times in patients with 
IBS, it is effective for IBS-C, but not for IBS-D. 
At the initial of the therapy, fiber supplementation 
should be given at small doses. The dose can be 
increased gradually. The fiber supplementation 
should be followed by an adequate fluid intake, 
as lack of fluid intake is associated with a number 
of adverse effects, including dehydration and 
stool impaction.2,11
Since older persons usually have disordered 
bowel function, a toilet training should be 
performed, particularly for those who are 
constipated. Older persons should be trained 
to have defecation in a good posture. The 
toiletting position should be modified to facilitate 
defecation, such as bending forward while seated 
on the toilet seat, or using a foot rest to raise the 
foot levels while having defecation.3
Medications
Since there is an altered risk-benefit profile 
in the elderly, drug safety should be taken into 
consideration in the management of IBS in 
the elderly. In addition, as aging is strongly 
associated to the presence of several geriatric 
problems, such as confusion, falls, urinary 
problem, as well as cardiac arrhytmias, the drug 
dose should be adjusted based on the patient’s 
condition individually. Furthermore, cognitive 
impairment is a common problem in the elderly. 
Therefore, several efforts should be made to 
overcome this problem, such as making a written 
instruction, to increase the patient’s compliance.3
Like the younger population, the medication 
is mainly directed to manage the predominant 
symptom, including constipation, diarrhea, and 
abdominal pain.3 A number of agents have been 
widely used to improve the symptoms of IBS, 
such as:
Pain
1. Analgesic. In some patients, analgesic is 
needed to reduce the pain. At the initial 
of therapy, paracetamol is preferred to 
nonsteroidal anti-inflammatory drugs 
(NSAID). Opiates is not recommended to be 
used in the elderly, as its use is associated with 
several adverse effects, such as dependence 
and addiction, which may be dangerous to 
the elderly. Furthermore, since NSAID and 
opiates may cause adverse effects on the 
gastrointestinal tract, these drugs should be 
used cautiously for those with prior history 
of gastrointestinal disorder.8
2. Antispasmodics. Since the symptoms of IBS 
may be created as a generalized response to 
eating, some patients might suffer from IBS 
symptoms, as a result of increased colonic 
motility in response to food or fluid intake. 
These symptoms could be reduced by the use 
of antispasmodic medications, which are best 
taken 30 minutes before meals. However, 
several randomized controlled trials have 
shown that these agents are useful in 
reducing pain, but not for reducing diarrhea 
or constipation. Like other anti-cholinergic 
drugs, antispasmodic agents may also cause 
several adverse effects, including blurred 
vision, dry mouth, fatigue, and urinary 
hesitancy. These agents should not be used 
in patients with narrow-angle glaucoma, or 
urinary retention.1,2,8,11
3. Tricyclic antidepressants (TCA). TCA can 
also be used in the treatment of IBS, as it 
may reduce the symptoms of abdominal 
pain or discomfort. The required dose is 
lower than that used to treat patients with 
depression. It was suggested that the benefit 
of TCA in reducing pain was unrelated to 
its anti-depressant effect. Several studies 
have suggested that TCA may reduce the 
pain sensitivity of peripheral nerves, thereby 
reducing the pain sensation. However, 
the exact mechanism of action is still 
unknown.1,2,8,11,12
 Since pain is commonly occured in 
patients with moderate to severe IBS, 
TCA is recommended to be used for these 
patients. However, the use of TCA is 
associated with an increased risk of having 
constipation. Thus, this agent should be 
used cautiously in patients with IBS-C. Like 
other antidepressants, TCA may also possess 
anti-cholinergic adverse effects which 
may be dangerous for older persons, such 
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as cardiac arrhytmias, confusion, blurred 
vision, dry mouth, and urinary retention. 
Thus, these agents should be given at a low 
dose, at the initial of the therapy. TCA is 
contraindicated for those with prior history 
of having cardiovascular disorder, autonomic 
dysfunction, or cognitive impairment.11,12
4. Selective serotonin reuptake inhibitors 
(SSRIs). Several randomized controlled 
trials have demonstrated that SSRIs, such as 
paroxetine, fluoxetine, and citalopram, could 
also be used in the management of IBS, as 
these agents may cause an improvement in 
the symptoms of IBS, including bloating, 
abdominal pain, and psychological stress. 
Furthermore, these agents may cause less 
adverse effects, when compared to TCA. 
However, some recent studies have found 
that different SSRIs may cause different 
effect to the patient’s body weight, either 
weight gain or weight loss. This factor should 
be taken into consideration, when prescribing 
SSRIs to older patients with IBS.1,2,8
5. Bifidobacterium infantis 35624. Currently, 
probiotics is commonly used in the treatment 
of gastrointestinal disorder, including IBS. 
Some recent studies have suggested that 
Bifidobacterium infantis 35624 is effective 
in reducing the symptoms of IBS, such 
as abdominal pain, bloating, as well as 
bowel movement disorder, regardless of the 
predominant bowel habit.6,8,13-15
Constipation
1. Laxatives. Since fiber, when used alone, is 
not effective in the treatment of moderate 
to severe constipation, the use of laxatives 
should be taken into consideration in this 
situation. Two groups of laxatives, such 
as osmotic laxatives (e.g. polyethylene 
glycol, lactulose and magnesium-containing 
products), and stimulant laxatives (e.g. 
bisacodyl and senna), are commonly used 
in patients with IBS-C.2,11
 Several studies have suggested that most 
osmotic laxatives are effective in reducing 
the symptom of constipation in IBS-C. In 
addition, the incidence of tachyphylaxis is 
rare. However, the use of some medications 
in this class, such as lactulose, might cause 
several gastrointestinal disorders, including 
bloating, abdominal pain, diarrhea, as well 
as dehydration. It should also be noted to use 
magnesium-containing laxatives cautiously 
in frail older persons, particularly for those 
with an elevation of serum creatinin.2,11
 Stimulant laxatives are also effective in 
reducing the symptom of constipation in 
patients with IBS-C. However, the use of 
these agents is associated with an increased 
risk of having serious adverse effects, 
including tachyphylaxis and dependency. 
Furthermore, several animal studies have 
demonstrated that stimulant laxatives may 
cause damages to the enteric neurons, 
including swelling and fragmentation. 
Therefore, these agents are not recommended 
to be used for long term use. Several 
studies have shown that although laxatives 
is effective in reducing the symptom of 
constipation, they only provide little benefit 
in reducing abdominal pain.2
2. Tegaserod. Since serotonin (5-HT) may 
play an important role in the gastrointestinal 
motility, serotonergic agents have been 
used widely in the treatment of several 
gastrointestinal disorders, including IBS. 
Tegaserod, the partial 5-HT4 agonist, is 
commonly used in reducing the symptom 
of constipation in IBS, since it may increase 
the colonic contractility. Unlike laxatives, 
several randomized controlled trials have 
demonstrated that the use of tegaserod is 
associated with an overall relief of IBS 
symptoms, such as pain and constipation.1,2
 Since IBS is associated with an alternation 
of bowel motility pattern, several studies 
have also examined the use of this agent in 
patients with IBS-D. It was reported that no 
complications or adverse effects occured 
within the use of this agent in IBS-D patients. 
However, tegaserod was withdrawn from the 
market in 2006 because of cardiovascular 
adverse effects in the elderly.1,2
3. Lubiprostone. Lubiprostone, a locally 
acting chloride channel activator, is another 
novel drug which is commonly used in 
reducing the symptom of constipation in 
patients with IBS-C. It should be noted 
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that this agent might cause several adverse 
effects, including nausea, diarrhea, as 
well as abdominal discomfort. Therefore, 
lubiprostone is recommended to be used in 
patients with severe constipation in whom 
other therapies have failed. However, further 
studies are needed to confirm the efficacy and 
safety of lubiprostone in treatment of IBS-C 
in the elderly.1,16
4. Bifidobacterium lactis DN-173 010.
Bifidobacterium lactis DN-173 010 is another 
probiotic product which is commonly used in 
the treatment of IBS-C. Several randomized 
controlled trials have demonstrated that 
B.lactis DN-173 010 is effective in reducing 
the symptom of constipation and improving 
the stool frequency, as it might increase 
colonic motility and reduce colonic transit 
times.8,13,17
Diarrhea
1. Loperamide. Loperamide may play a role 
in reducing the gut motility by binding 
to specific opiate receptors in the enteric 
nervous system. Several studies have 
suggested that loperamide can be used for 
long term use, since it does not have an anti-
cholinergic component. However, although 
loperamide is effective in reducing the 
symptom of diarrhea and improving stool 
consistency, several randomized controlled 
trials have demonstrated that it is no more 
effective in reducing abdominal pain, when 
compared to the placebo. Furthermore, 
since impaction is commonly occured in 
the elderly, it is important to exclude the 
presence this disoder before assessing that 
the patient is suffered from diarrhea and 
giving anti-diarrheal medications.2,8,11
2. Alosetron. As mentioned before, currently, 
serotonergic agents are commonly used 
in the treatment of several gastrointestinal 
disorders, including IBS. Several studies 
have demonstrated that alosetron, a 
selective 5-HT3 antagonist, is effective in 
the treatment of severe IBS-D in whom 
other approaches have been unsuccessful. 
Alosetron might block the serotonin receptor, 
thereby reducing visceral pain sensation 
and colonic motility. Therefore, alosetron 
is effective in reducing global symptoms of 
IBS, including abdominal pain.1,8
 However, the use of alosetron is strongly 
associated with an increased risk of having 
constipation. Furthermore, several studies 
have reported the incidence of ischemic 
colitis within the use of this agent in the 
elderly. Thus, alosetron is only recommended 
for older patients with IBS-D who have 
symptoms >6 months and showed a lack of 
response to the treatment with other anti-
diarrheal medications.1,8
PSYCHOLOGICAL TREATMENTS
Since IBS is strongly associated with 
psychological disorders, psychological 
treatments are recommended for IBS patients 
in such conditions, such as moderate to severe 
symptoms of IBS, when other therapies have 
been failed, or when stress or psychological 
factor is highly likely contributing to the 
development of the gastrointestinal symptoms.4,10
Currently, 4 major types of psychological 
treatments are commonly used in the treatment 
of IBS: 
1. Cognitive-Behavioral Treatment (CBT) is 
a technique where the patients are trained 
to correct maladaptive thoughts by using 
diaries and doing exercises with the therapist. 
The aim of this treatment is to achieve an 
adequate control over the symptoms of IBS.
2. P s y c h o d y n a m i c  o r  i n t e r p e r s o n a l 
psychotherapy is a technique where the 
patients are trained to search for any 
difficulties in their interpersonal relationships 
which may promote or worsen the 
gastrointestinal symptoms.
3. Hypnosis is a technique where positive 
insights are delivered from the therapist to the 
patients in the form of hypnotic suggestions. 
This technique is used to normalize the bowel 
movement, thereby reducing gastrointestinal 
symptoms.
4. Stress management/relaxation training is a 
technique to stabilize the patients’ autonomic 
activity and muscle tension by using imaging 
and relaxation methods.
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All of these psychotherapy techniques, when 
used alone or in combination, are effective in 
reducing the symptoms of IBS.4,9,10
Several studies reported that CBT is the most 
commonly used in the treatment of IBS. CBT is 
also reported as the best studied psychological 
treatment for IBS. However, some recent studies 
have demonstrated that CBT, when used alone, 
is not effective to reduce the symptoms if the 
patients had severe depression. Therefore, in 
patients with severe depression, CBT should 
be given in combination with other form of 
therapies, such as anti-depressant medications.1,11
CONCLUSION
IBS is one of the most common gastrointestinal 
problems in the elderly. Diagnosis of IBS in 
the elderly is not different from the younger 
populations. However, aging itself is categorized 
as one of the alarm symptoms in the diagnosis 
of IBS. Therefore, exclusion of organic diseases, 
using several investigations, is of paramount 
important in the older patients. Overall, the 
treatment of IBS in the elderly should be 
arranged the same way as younger patients. 
However, greater caution needs to be considered 
before prescribing because of the altered risk-
benefit profile in the elderly.
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